Improving Lymphedema Care in O&P

In this episode of O&P Clinical Care Insiders: Industry Partners Edition, host Seth O'Brien, CP, FAAOP(D), speaks with Lindsay E. Ryback, director of lymphology & phlebology at Thuasne, and Lesleigh Sisson, CFo, CFm, vice president and general manager of O&P Insight. Recorded live at the 51st Academy Annual Meeting in Atlanta, the conversation explores lymphedema, a chronic condition caused by abnormal lymph fluid buildup. Lindsay and Lesleigh discuss treatment options, including Complete Decongestive Therapy and compression therapy, and break down the impact of the newly passed Lymphedema Treatment Act. They highlight the power of patient advocacy in shaping this legislation and what it means for coverage, reimbursement, and O&P practices looking to integrate lymphedema care. Lindsay also shares how Thuasne's products and resources support clinicians in delivering effective treatment.

This episode is sponsored by Thuasne and O&P Insight

Show notes

The following links were mentioned during this podcast episode.

Lymphedema Compression Treatment Items (from CMS.gov)

Lymphedema Advocacy Group

Lymphedema Compression Treatment Items: Implementation (from CMS.gov)

O&P Clinical Care Insiders: Industry Partners Edition is produced by Association Briefings.